Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Maria V. Camarasa"'
Autor:
Maria V. Camarasa
Publikováno v:
Recent Patents on Regenerative Medicine. 5:85-101
Autor:
Maria V. Camarasa-Sabater
Publikováno v:
Recent Patents on Regenerative Medicine. 5:27-35
Publikováno v:
Stem Cell Research & Therapy. 7
Cystic fibrosis is one of the most frequent inherited rare diseases, caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Apart from symptomatic treatments, therapeutic protocols for curing the disease have not yet bee
Autor:
Maria V. Camarasa
Publikováno v:
Recent Patents on Regenerative Medicine. 2:37-56
The establishment of the first culture of a human embryonic stem cell (hESC) line as immortal and capable of producing virtually every cell of a human body generated high expectations regarding their potential use in regenerative medicine and researc
Autor:
Maureen Mee, Banu Iskender, Tristan R. McKay, John D. Aplin, Daniel E. Foxler, Maria V. Camarasa, Duncan Miller, Jayne C. Fitzsimmons, Susan J. Kimber, Tyson V. Sharp, Nicola Bates, Jinpei Ye, Daniel R. Brison
Publikováno v:
Stem Cell Research. 7(2):154-162
We have generated a human feeder cell line from early second trimester Placental Stromal Fibroblasts (ihPSF) stably over-expressing the polycomb protein BMI-1. These feeder cells retain the ability to maintain human Embryonic Stem cells (hESc) over l
Autor:
Rachel A. Oldershaw, Tristan R. McKay, Lisa Shaw, Nicola Bates, Daniel R. Brison, Maria V. Camarasa, Sharon Sneddon, Fiona Small, Melissa A. Baxter, Susan J. Kimber, Robbie W. Kerr
Publikováno v:
In Vitro Cellular & Developmental Biology - Animal. 46:386-394
We report here the derivation of two new human embryonic stem cell lines, Man-1 and Man-2, and their full characterization as novel pluripotent stem cell lines. Man-1 was derived from an embryo surplus to requirement from routine IVF, while Man-2 was
Autor:
Estefania Carrasco-Garcia, Maria V. Camarasa, José A. Ferragut, María D. Castro-Galache, Miguel Saceda, P. Garcia-Morales
Publikováno v:
Journal of Cellular Biochemistry. 94:98-108
It is well established that the effectiveness of anticancer drugs may result from combined cytotoxic and differentiation activities on tumor cells. Also, differentiating agents are able to alter the susceptibility of cancer cells to antineoplastic dr
Publikováno v:
Stem Cell Research & Therapy, Vol 8, Iss 1, Pp 1-1 (2017)
Cystic fibrosis is one of the most frequent inherited rare diseases, caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Apart from symptomatic treatments, therapeutic protocols for curing the disease have not yet bee
Autor:
Maria V. Camarasa, Mayol Mj, Calpena R, Lacueva Fj, Teruel A, Pérez-Vázquez Mt, José A. Ferragut, J Medrano, Rufete C
Publikováno v:
Histopathology. 32:328-334
Aims: Most chemotherapeutic regimens used against gastric carcinoma include anthracyclines whose effectiveness can be impaired by the presence of P-glycoprotein. In order to obtain a reliable pattern of P-glycoprotein expression in these tumours an i
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
For the past 12 years, the biology and applications of human embryonic stem cells (hESCs) have received great attention from the scientific community. Derivatives of the first hESC line obtained by J. Thomson's group (Science 282(5391):1145-1147, 199